Marc Saner [4]Marc A. Saner [1]M. Saner [1]
  1.  9
    Beyond Cost-Benefit Analysis in the Governance of Synthetic Biology.Wendell Wallach, Marc Saner & Gary Marchant - 2018 - Hastings Center Report 48 (S1):S70-S77.
    Direct download  
    Export citation  
    Bookmark   3 citations  
  2.  27
    Biotechnology, the Limits of Norton's Convergence Hypothesis, and Implications for an Inclusive Concept of Health.M. Saner - 2000 - Ethics and the Environment 5 (2):229-241.
    Bryan Norton proposes a "convergence hypothesis'* stating that anthropocentrists and nonanthropocentrists can arrive at common environmental policy goals if certain constraints are applied. Within his theory he does not, however, address the consideration ofnonconsequentualist issues, and, therefore, does not provide an argument for the convergence between consequentualist and nonconsequentualist ethical positions. In the case of biotechnology, nonconsequentualist issues can dominate the debate in both the fields of environmental ethics and bioethics. I argue that, the convergence hypothesis must be rejected when (...)
    Direct download (5 more)  
    Export citation  
    Bookmark   4 citations  
  3.  25
    Citizenship Engagement, Biotechnology and ICTs.Marc Saner - 2006 - Techne 9 (3):14-22.
  4.  18
    On the Public Controversy Over the Regulation of Risk: Towards A Professional Ethics For Risk Evaluators.Marc A. Saner - 2003 - Professional Ethics, a Multidisciplinary Journal 11 (4):79-85.
    Direct download (3 more)  
    Export citation